Bone Therapeutics SA Stock Euronext Bruxelles
Equities
BOTHE
BE0974280126
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.7M 2.94M 0 3.99M |
---|---|---|---|---|---|
Net income 2023 * | -5M -5.44M - -7.4M | Net income 2024 * | -11M -11.97M - -16.28M | EV / Sales 2023 * | - |
Net Debt 2023 * | 18.8M 20.45M 0 27.83M | Net Debt 2024 * | 29.3M 31.88M 0 43.37M | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.29
x | P/E ratio 2024 * |
-0.16
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.65% |
Managers | Title | Age | Since |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-02 |
Nicco Carole
COO | Chief Operating Officer | - | 23-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.76% | 364B | |
+20.59% | 326B | |
+5.64% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.02% | 167B | |
+0.09% | 161B |
- Stock Market
- Equities
- BIOS Stock
- BOTHE Stock